Insights

Recent Expansion Boundless Bio has shown significant growth and momentum through multiple funding rounds, hiring key executives, and initiating new ecDNA programs, indicating opportunities for partnering and collaborations in the biotechnology sector.

Public Listings Being a publicly listed company and continuously raising substantial funds through IPOs and Series C funding, Boundless Bio presents potential sales opportunities for service providers, investors, and suppliers seeking to engage with a growing and financially robust organization.

Research Innovation As a pioneering company focused on developing novel cancer therapeutics targeting extrachromosomal DNA, Boundless Bio's innovative approach offers sales prospects for technology suppliers, research institutions, and pharma companies looking to access cutting-edge oncology solutions.

Key Personnel Appointments With strategic appointments of experienced professionals like Jami Rubin and Wagner to key roles, Boundless Bio demonstrates a commitment to enhancing its leadership team, presenting opportunities for HR solutions, executive training services, and other support services providers.

Competitive Landscape Situated among similar biotech companies, including Genomic Health, Invitae, and Natera, Boundless Bio's distinct focus on ecDNA therapies offers a unique positioning in the market, allowing for tailored sales strategies targeting specific niches within the industry.

Boundless Bio Tech Stack

Boundless Bio uses 8 technology products and services including MySQL, Shopify, Google Cloud, and more. Explore Boundless Bio's tech stack below.

  • MySQL
    Database
  • Shopify
    E-commerce
  • Google Cloud
    Infrastructure As A Service
  • Google Cloud Platform
    Infrastructure As A Service
  • Microsoft
    Miscellaneous
  • Microsoft Azure
    Platform As A Service
  • PHP
    Programming Languages
  • Java
    Programming Languages

Media & News

Boundless Bio's Email Address Formats

Boundless Bio uses at least 1 format(s):
Boundless Bio Email FormatsExamplePercentage
FLast@boundlessbio.comJDoe@boundlessbio.com
71%
Last@boundlessbio.comDoe@boundlessbio.com
27%
FirstLast@boundlessbio.comJohnDoe@boundlessbio.com
1%
First.Last@boundlessbio.comJohn.Doe@boundlessbio.com
1%

Frequently Asked Questions

Where is Boundless Bio's headquarters located?

Minus sign iconPlus sign icon
Boundless Bio's main headquarters is located at 10955 Alexandria Way Suite 100 San Diego, CA 92121 US. The company has employees across 2 continents, including North AmericaEurope.

What is Boundless Bio's stock symbol?

Minus sign iconPlus sign icon
Boundless Bio is a publicly traded company; the company's stock symbol is BOLD.

What is Boundless Bio's official website and social media links?

Minus sign iconPlus sign icon
Boundless Bio's official website is boundlessbio.com and has social profiles on LinkedIn.

How much revenue does Boundless Bio generate?

Minus sign iconPlus sign icon
As of November 2024, Boundless Bio's annual revenue reached $15M.

What is Boundless Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
Boundless Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Boundless Bio have currently?

Minus sign iconPlus sign icon
As of November 2024, Boundless Bio has approximately 82 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer And President: Z. H.Chief Business Officer: N. A.Chief Legal Officer, Corporate Secretary; Head Of Quality: J. O.. Explore Boundless Bio's employee directory with LeadIQ.

What industry does Boundless Bio belong to?

Minus sign iconPlus sign icon
Boundless Bio operates in the Biotechnology Research industry.

What technology does Boundless Bio use?

Minus sign iconPlus sign icon
Boundless Bio's tech stack includes MySQLShopifyGoogle CloudGoogle Cloud PlatformMicrosoftMicrosoft AzurePHPJava.

What is Boundless Bio's email format?

Minus sign iconPlus sign icon
Boundless Bio's email format typically follows the pattern of . Find more Boundless Bio email formats with LeadIQ.

How much funding has Boundless Bio raised to date?

Minus sign iconPlus sign icon
As of November 2024, Boundless Bio has raised $100M in funding. The last funding round occurred on May 16, 2023 for $100M.
Boundless Bio

Boundless Bio

Biotechnology ResearchCalifornia, United States51-200 Employees

Boundless Bio is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence.

When DNA in cancer cells comes off chromosomes, “extrachromosomal DNA (ecDNA),” it becomes unbound and unwound, thereby enabling numerous copies of cancer-causing genes,  driving cancer cells to grow and allowing them to resist treatment.  At Boundless Bio, we are counterattacking this ecDNA phenomenon with boundless innovation and boundless energy to develop powerful new cancer medicines that eliminate cancer cells’ ability to employ ecDNA to survive.

Our Culture:

At Boundless, you’ll experience what it means to be out in front of the wave. 
Our unprecedented science takes us to new shores, and our team navigates the best breaks. We’re leaders in our field, and we’re dedicated to the cause of understanding and treating intractable cancers.

Every employee at Boundless makes an unbridled impact on our capabilities and our culture. We’ll help you expand your abilities and defy your bounds by providing meaningful work and unbounded opportunities. Career development is essential at Boundless. 

We’re all in on this fight against cancer– collaboration is requisite to our success. We have a team of people who ask, offer, and accept help without regard for ego. We know that receiving support is energizing, and giving help is fulfilling. We are inspired by the patients who are reliant upon our success. 

At Boundless, we’re all in. We are unbound by convention, bound to save lives. 


Career Inquiries
careers@boundlessbio.com

General Information Inquiries
info@boundlessbio.com

Section iconCompany Overview

Headquarters
10955 Alexandria Way Suite 100 San Diego, CA 92121 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BOLD
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $100M

    Boundless Bio has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on May 16, 2023 in the amount of $100M.

  • $10M$50M

    Boundless Bio's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $100M

    Boundless Bio has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on May 16, 2023 in the amount of $100M.

  • $10M$50M

    Boundless Bio's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.